Skip to main content
Journal cover image

Major Adverse Cardiovascular Events After 12 Months Among Patients With Acute Coronary Syndrome Receiving Loading Doses of Atorvastatin Prior to Planned PCI.

Publication ,  Journal Article
Lopes, RD; de Barros E Silva, PGM; Damiani, LP; Santos, RHN; Alexander, JH; Granger, CB; Berwanger, O
Published in: JAMA
February 2020

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA

DOI

EISSN

1538-3598

ISSN

0098-7484

Publication Date

February 2020

Volume

323

Issue

8

Start / End Page

787 / 789

Related Subject Headings

  • Percutaneous Coronary Intervention
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • General & Internal Medicine
  • Cardiovascular Diseases
  • Atorvastatin
  • Acute Coronary Syndrome
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lopes, R. D., de Barros E Silva, P. G. M., Damiani, L. P., Santos, R. H. N., Alexander, J. H., Granger, C. B., & Berwanger, O. (2020). Major Adverse Cardiovascular Events After 12 Months Among Patients With Acute Coronary Syndrome Receiving Loading Doses of Atorvastatin Prior to Planned PCI. JAMA, 323(8), 787–789. https://doi.org/10.1001/jama.2020.0118
Lopes, Renato D., Pedro G. M. de Barros E Silva, Lucas Petri Damiani, Renato Hideo Nakagawa Santos, John H. Alexander, Christopher B. Granger, and Otavio Berwanger. “Major Adverse Cardiovascular Events After 12 Months Among Patients With Acute Coronary Syndrome Receiving Loading Doses of Atorvastatin Prior to Planned PCI.JAMA 323, no. 8 (February 2020): 787–89. https://doi.org/10.1001/jama.2020.0118.
Lopes RD, de Barros E Silva PGM, Damiani LP, Santos RHN, Alexander JH, Granger CB, et al. Major Adverse Cardiovascular Events After 12 Months Among Patients With Acute Coronary Syndrome Receiving Loading Doses of Atorvastatin Prior to Planned PCI. JAMA. 2020 Feb;323(8):787–9.
Lopes, Renato D., et al. “Major Adverse Cardiovascular Events After 12 Months Among Patients With Acute Coronary Syndrome Receiving Loading Doses of Atorvastatin Prior to Planned PCI.JAMA, vol. 323, no. 8, Feb. 2020, pp. 787–89. Epmc, doi:10.1001/jama.2020.0118.
Lopes RD, de Barros E Silva PGM, Damiani LP, Santos RHN, Alexander JH, Granger CB, Berwanger O. Major Adverse Cardiovascular Events After 12 Months Among Patients With Acute Coronary Syndrome Receiving Loading Doses of Atorvastatin Prior to Planned PCI. JAMA. 2020 Feb;323(8):787–789.
Journal cover image

Published In

JAMA

DOI

EISSN

1538-3598

ISSN

0098-7484

Publication Date

February 2020

Volume

323

Issue

8

Start / End Page

787 / 789

Related Subject Headings

  • Percutaneous Coronary Intervention
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • General & Internal Medicine
  • Cardiovascular Diseases
  • Atorvastatin
  • Acute Coronary Syndrome
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences